Magellan MAR01 Therapy

· Arteriocyte, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Magellan MAR01 Therapy, covering 2017-04-13 to 2017-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase I, Arteriocyte Magellan MAR01 Therapy - Compartment Syndrome and Battlefield Trauma [Phase 1]